Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma Journal Article


Authors: Li, L.; Xu-Monette, Z. Y.; Ok, C. Y.; Tzankov, A.; Manyam, G. C.; Sun, R.; Visco, C.; Zhang, M.; Montes-Moreno, S.; Dybkaer, K.; Chiu, A.; Orazi, A.; Zu, Y.; Bhagat, G.; Richards, K. L.; Hsi, E. D.; Choi, W. W. L.; van Krieken, J. H.; Huh, J.; Ponzoni, M.; Ferreri, A. J. M.; Møller, M. B.; Wang, J.; Parsons, B. M.; Winter, J. N.; Piris, M. A.; Pham, L. V.; Jeffrey Medeiros, L.; Young, K. H.
Article Title: Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma
Abstract: Dysregulated NF-κB signaling is critical for lymphomagenesis. The regulation, function, and clinical relevance of c-Rel/NF-κB activation in diffuse large B-cell lymphoma (DLBCL) have not been well studied. In this study we analyzed the prognostic significance and gene-expression signature of c-Rel nuclear expression as surrogate of c-Rel activation in 460 patients with de novo DLBCL. Nuclear c-Rel expression, observed in 137 (26.3%) DLBCL patients frequently associated with extranoal origin, did not show significantly prognostic impact in the overall- or germinal center B-like-DLBCL cohort, likely due to decreased pAKT and Myc levels, up-regulation of FOXP3, FOXO3, MEG3 and other tumor suppressors coincided with c-Rel nuclear expression, as well as the complicated relationships between NF-κB members and their overlapping function. However, c-Rel nuclear expression correlated with significantly poorer survival in p63+ and BCL-2- activated B-cell-like-DLBCL, and in DLBCL patients with TP53 mutations. Multivariate analysis indicated that after adjusting clinical parameters, c-Rel positivity was a significantly adverse prognostic factor in DLBCL patients with wild type TP53. Gene expression profiling suggested dysregulations of cell cycle, metabolism, adhesion, and migration associated with c-Rel activation. In contrast, REL amplification did not correlate with c-Rel nuclear expression and patient survival, likely due to co-amplification of genes that negatively regulate NF-κB activation. These insights into the expression, prognostic impact, regulation and function of c-Rel as well as its crosstalk with the p53 pathway underscore the importance of c-Rel and have significant therapeutic implications.
Keywords: protein kinase b; adult; cancer survival; controlled study; human tissue; protein expression; gene mutation; human cell; major clinical study; protein function; transcription factor foxp3; cell cycle; protein bcl 2; gene amplification; gene expression profiling; protein protein interaction; cohort analysis; immunoglobulin enhancer binding protein; wild type; protein p53; tumor suppressor gene; enzyme phosphorylation; myc protein; cell migration; protein p63; upregulation; cell nucleus; large cell lymphoma; cancer classification; cell adhesion; transcription factor fkhrl1; p53; metabolic regulation; dlbcl; nf-κb; transcription factor rel; c-rel; cancer prognosis; human; male; female; article; rel gene; foxp3 gene; foxo3 gene; germinal center b like diffuse large b cell lymphoma; meg3 gene
Journal Title: Oncotarget
Volume: 6
Issue: 27
ISSN: 1949-2553
Publisher: Impact Journals  
Date Published: 2015-09-15
Start Page: 23157
End Page: 23180
Language: English
DOI: 10.18632/oncotarget.4319
PROVIDER: scopus
PUBMED: 26324762
PMCID: PMC4695110
DOI/URL:
Notes: Export Date: 2 November 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. April Chiu
    57 Chiu